n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Acute Confusional Senile Dementia in 2 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maher, A | 1 |
El-Sayed, NS | 1 |
Breitinger, HG | 1 |
Gad, MZ | 1 |
Chabrier, PE | 1 |
Demerlé-Pallardy, C | 1 |
Auguet, M | 1 |
1 review available for n-(3-(aminomethyl)benzyl)acetamidine and Acute Confusional Senile Dementia
Article | Year |
---|---|
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; B | 1999 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Acute Confusional Senile Dementia
Article | Year |
---|---|
Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: modulation by NOS inhibitors.
Topics: Alzheimer Disease; Amidines; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal | 2014 |